IDXG
insider transactionsINTERPACE BIOSCIENCES, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·C
Ampersand 2018 Limited Partnership
10% Owner
$0
28.0K sh
Own New
-
Exercise·C
Ampersand 2018 Limited Partnership
10% Owner
$28.0M
13.9M sh · $2.02
Own New
-
Exercise·C
10% Owner
$0
19.0K sh
Own New
-
Exercise·C
10% Owner
$19.0M
9.4M sh · $2.02
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jan 20, 2026 | Ampersand 2018 Limited Partnership | Exercise C | 28.0K | $0 |
| Jan 20, 2026 | Ampersand 2018 Limited Partnership | Exercise C | 13.9M | $28.0M |
| Jan 20, 2026 | 1315 Capital II, L.P. | Exercise C | 19.0K | $0 |
| Jan 20, 2026 | 1315 Capital II, L.P. | Exercise C | 9.4M | $19.0M |
About IDXG insider trading
This page tracks insider transactions for INTERPACE BIOSCIENCES, INC. (IDXG) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.